Baltimore, MD, United States of America

Paul M Kim

This inventor holds 1 USPTO granted patent. Top assignee: Johns Hopkins University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul M Kim. Retrieved from https://idiyas.com/inventor/paul-m-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paul M. Kim: Inventor in Biomedical Research

Introduction

Paul M. Kim is an inventor associated with Johns Hopkins University in Baltimore, Maryland. His patent work concerns potential therapeutic approaches for multiple sclerosis and other neurological disorders.

Latest Patents

The available information identifies one patent associated with Kim: “Methods, Compositions and Kits for Treating Multiple Sclerosis and Other Disorders.” The disclosure describes methods involving administration of a therapeutically effective amount of a bryostatin compound. The proposed applications include treating multiple sclerosis and its symptoms, preventing symptom onset in people with or predisposed to the condition, and promoting immunomodulation, remyelination, or myelin repair. It also addresses neuroinflammatory disorders, amyotrophic lateral sclerosis, demyelinating diseases, and hypomyelinating conditions. The patent record lists 1 patent.

Career Highlights

Kim’s listed patent connects his work with research into therapeutic strategies for neurological and immune-related conditions. His affiliation with Johns Hopkins University places this work within a university research setting.

Collaborations

The provided information names Michael D. Kornberg and Peter A. Calabresi as Kim’s coworkers. Their names are associated with the collaborative research context described in the patent information.

Conclusion

Paul M. Kim’s identified patent focuses on bryostatin-based methods and compositions proposed for multiple sclerosis and several related neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…